• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的组织病理学、分级与分期

Histopathology, grading and staging of nonalcoholic fatty liver disease.

作者信息

Kleiner David E

机构信息

Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA -

出版信息

Minerva Gastroenterol Dietol. 2018 Mar;64(1):28-38. doi: 10.23736/S1121-421X.17.02445-X. Epub 2017 Sep 25.

DOI:10.23736/S1121-421X.17.02445-X
PMID:28948754
Abstract

Nonalcoholic fatty liver disease (NAFLD) is the liver disease associated with obesity, diabetes and the metabolic syndrome. Although steatosis is a key histological feature, liver biopsies of patients with NAFLD can show a wide range of other findings, including portal and lobular inflammation, ballooning and apoptotic hepatocellular injury, Mallory-Denk bodies, megamitochondria and fibrosis. Nonalcoholic steatohepatitis (NASH) is a progressive subtype of NAFLD first defined by analogy to alcoholic hepatitis. The characteristic finding in NASH is ballooning hepatocellular injury. The fibrosis pattern is distinctive, with perisinusoidal fibrosis around the central veins being the first manifestation of fibrosis. Young children may have an alternate pattern of progressive NAFLD characterized by a zone 1 distribution of steatosis, inflammation and fibrosis. Several grading and staging systems exist for use in natural history studies and clinical trials, each with some advantages and disadvantages. These include the Brunt system, the NASH CRN system and the SAF system. Each of these systems has been applied to clinical studies permitting correlation of laboratory and demographic observations with histological findings.

摘要

非酒精性脂肪性肝病(NAFLD)是一种与肥胖、糖尿病和代谢综合征相关的肝脏疾病。虽然脂肪变性是关键的组织学特征,但NAFLD患者的肝活检可显示出广泛的其他表现,包括门脉和小叶炎症、气球样变及凋亡性肝细胞损伤、马洛里-登克小体、巨型线粒体和纤维化。非酒精性脂肪性肝炎(NASH)是NAFLD的一种进行性亚型,最初是通过与酒精性肝炎类比而定义的。NASH的特征性表现是气球样变肝细胞损伤。纤维化模式独特,中央静脉周围的窦周纤维化是纤维化的首发表现。幼儿可能有一种不同的进行性NAFLD模式,其特征为脂肪变性、炎症和纤维化呈1区分布。有几种分级和分期系统用于自然史研究和临床试验,每种都有一些优缺点。这些系统包括布伦特系统、NASH CRN系统和SAF系统。这些系统中的每一个都已应用于临床研究,从而使实验室和人口统计学观察结果与组织学发现相关联。

相似文献

1
Histopathology, grading and staging of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的组织病理学、分级与分期
Minerva Gastroenterol Dietol. 2018 Mar;64(1):28-38. doi: 10.23736/S1121-421X.17.02445-X. Epub 2017 Sep 25.
2
NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review.非酒精性脂肪性肝病(MASLD)/非酒精性脂肪性肝炎(MASH):是否有必要进行标记?全面的叙述性综述。
Int J Mol Sci. 2024 Aug 2;25(15):8462. doi: 10.3390/ijms25158462.
3
Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.成人及儿童非酒精性脂肪性肝病和非酒精性脂肪性肝炎的组织学
Clin Liver Dis. 2016 May;20(2):293-312. doi: 10.1016/j.cld.2015.10.011. Epub 2015 Dec 28.
4
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
5
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.非酒精性脂肪性肝炎:关于组织学病变分级和分期的建议。
Am J Gastroenterol. 1999 Sep;94(9):2467-74. doi: 10.1111/j.1572-0241.1999.01377.x.
6
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的组织病理学
Metabolism. 2016 Aug;65(8):1080-6. doi: 10.1016/j.metabol.2015.11.008. Epub 2015 Dec 2.
7
Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.非酒精性脂肪性肝病——组织学评分系统:一项大型队列单中心评估研究。
APMIS. 2017 Nov;125(11):962-973. doi: 10.1111/apm.12742.
8
Histopathological Diagnosis of Nonalcoholic Steatohepatitis (NASH).非酒精性脂肪性肝炎(NASH)的组织病理学诊断。
Methods Mol Biol. 2022;2455:1-18. doi: 10.1007/978-1-0716-2128-8_1.
9
Pathology of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的病理学。
Liver Int. 2017 Jan;37 Suppl 1:85-89. doi: 10.1111/liv.13301.
10
Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的组织病理学发现。
J Med Ultrason (2001). 2020 Oct;47(4):549-554. doi: 10.1007/s10396-020-01061-3. Epub 2020 Nov 2.

引用本文的文献

1
Serum protein risk stratification score for diagnostic evaluation of metabolic dysfunction-associated steatohepatitis.用于代谢功能障碍相关脂肪性肝炎诊断评估的血清蛋白风险分层评分
Hepatol Commun. 2024 Nov 29;8(12). doi: 10.1097/HC9.0000000000000586. eCollection 2024 Dec 1.
2
NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review.非酒精性脂肪性肝病(MASLD)/非酒精性脂肪性肝炎(MASH):是否有必要进行标记?全面的叙述性综述。
Int J Mol Sci. 2024 Aug 2;25(15):8462. doi: 10.3390/ijms25158462.
3
Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD.
1260例非肝硬化性非酒精性脂肪性肝病患者的长期主要肝脏不良结局
JHEP Rep. 2023 Sep 25;6(2):100915. doi: 10.1016/j.jhepr.2023.100915. eCollection 2024 Feb.
4
MicroRNAs and Nonalcoholic Steatohepatitis: A Review.微小 RNA 与非酒精性脂肪性肝炎:综述。
Int J Mol Sci. 2023 Sep 23;24(19):14482. doi: 10.3390/ijms241914482.
5
Comparative Analysis of Global Hepatic Gene Expression in Adolescents and Adults with Non-alcoholic Fatty Liver Disease.青少年和成人非酒精性脂肪性肝病患者肝脏基因表达的全球比较分析
Arch Clin Biomed Res. 2023;7(1):112-119. doi: 10.26502/acbr.50170323. Epub 2023 Feb 20.
6
Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH).外泌体 microRNAs 与非酒精性脂肪性肝炎(NASH)的进展。
Int J Mol Sci. 2022 Nov 4;23(21):13501. doi: 10.3390/ijms232113501.
7
Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liver.通过阻断肝脏中的线粒体融合来预防和逆转巨型线粒体和脂肪变性
iScience. 2022 Feb 26;25(4):103996. doi: 10.1016/j.isci.2022.103996. eCollection 2022 Apr 15.
8
Priming, Triggering, Adaptation and Senescence (PTAS): A Hypothesis for a Common Damage Mechanism of Steatohepatitis.原代细胞触发适应和衰老(PTAS):一种非酒精性脂肪性肝炎共同损伤机制的假说。
Int J Mol Sci. 2021 Nov 21;22(22):12545. doi: 10.3390/ijms222212545.
9
Post-mortem differential diagnosis from COVID-19: A case of fulminant myocarditis HHV-6 related.与COVID-19进行的死后鉴别诊断:一例HHV-6相关暴发性心肌炎病例。
Pathol Int. 2022 Jan;72(1):75-78. doi: 10.1111/pin.13184. Epub 2021 Nov 8.
10
Pediatric nonalcoholic fatty liver disease - a changing diagnostic paradigm.小儿非酒精性脂肪性肝病——不断变化的诊断模式。
Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1023-1031. doi: 10.47162/RJME.61.4.04.